Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.38B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$685M |
| 3 |
Home Depot
HD
|
+$497M |
| 4 |
Bausch Health
BHC
|
+$314M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$418M |
| 2 |
AT&T
T
|
+$243M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$193M |
| 4 |
Southern Company
SO
|
+$163M |
| 5 |
DELL
DELL INC
DELL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.21% |
| 2 | Financials | 5.16% |
| 3 | Technology | 4.66% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Energy | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6301
Limoneira
LMNR
$235M
| $34K | ﹤0.01% |
1,295
+919
| +244% | +$23.3K |
|
|
MVO
6302
DELISTED
MV Oil Trust
MVO
| $34K | ﹤0.01% |
1,480
+900
| +155% | +$24.1K |
|
6303
CALL
Xylem
XYL
$27.3B
| $34K | ﹤0.01% |
1,000
-4,900
| -83% | -$158K |
|
|
VCRA
6304
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $34K | ﹤0.01% |
2,292
-542
| -19% | -$9.26K |
|
|
RGC
6305
PUT
DELISTED
Regal Entertainment Group
RGC
| $34K | ﹤0.01% |
1,800
-2,900
| -62% | -$55.6K |
|
|
LUX
6306
DELISTED
Luxottica Group
LUX
| $34K | ﹤0.01% |
640
-375
| -37% | -$19.4K |
|
|
EQU
6307
DELISTED
EQUAL ENERGY LTD COM
EQU
| $34K | ﹤0.01% |
6,610
+6,222
| +1,604% | +$30.6K |
|
|
GSE
6308
DELISTED
GSE HLDG INC COM STK (DE)
GSE
| $34K | ﹤0.01% |
17,374
+3,847
| +28% | +$9.3K |
|
|
VPHM
6309
CALL
DELISTED
VIROPHARMA INC
VPHM
| $34K | ﹤0.01% |
700
-249,200
| -100% | -$11.1M |
|
6310
Peraso
PRSO
$9.78M
| $33K | ﹤0.01% |
1
| – | – |
|
6311
Twin Disc
TWIN
$329M
| $33K | ﹤0.01% |
1,330
+1,247
| +1,502% | +$32.9K |
|
6312
WIX.com
WIX
$2.3B
| $33K | ﹤0.01% |
+1,270
| New | +$28.2K |
|
|
CHUY
6313
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $33K | ﹤0.01% |
904
+295
| +48% | +$10.6K |
|
|
GARS
6314
DELISTED
Garrison Capital Inc.
GARS
| $33K | ﹤0.01% |
2,541
+938
| +59% | +$13.5K |
|
|
GST
6315
DELISTED
Gastar Exploration Inc.
GST
| $33K | ﹤0.01% |
5,464
-24,087
| -82% | -$120K |
|
|
ANEN
6316
DELISTED
ANAREN INC
ANEN
| $33K | ﹤0.01% |
1,267
-1,836
| -59% | -$49.7K |
|
|
CHU
6317
CALL
DELISTED
China Unicom (HONG KONG) Limited
CHU
| $33K | ﹤0.01% |
2,200
-10,800
| -83% | -$169K |
|
6318
CAE Inc. Common Shares
CAE
$8.3B
| $32K | ﹤0.01% |
2,672
-470
| -15% | -$5.41K |
|
6319
Clarus
CLAR
$123M
| $32K | ﹤0.01% |
2,406
+2,180
| +965% | +$28.9K |
|
6320
CALL
Comstock Resources
CRK
$3.89B
| $32K | ﹤0.01% |
360
-7,160
| -95% | -$622K |
|
6321
CALL
Ducommun
DCO
$2.7B
| $32K | ﹤0.01% |
1,100
-8,100
| -88% | -$220K |
|
|
6322
PUT
Ducommun
DCO
$2.7B
| $32K | ﹤0.01% |
+1,100
| New | +$29.9K |
|
6323
Global Partners
GLP
$1.68B
| $32K | ﹤0.01% |
+900
| New | +$31.1K |
|
|
IAE
6324
Voya Asia Pacific High Dividend Equity Income Fund
IAE
$91.8M
| $32K | ﹤0.01% |
+2,644
| New | +$34.4K |
|
|
SPNS
6325
DELISTED
Sapiens International
SPNS
| $32K | ﹤0.01% |
+4,523
| New | +$30.9K |
|
Similar funds
Barclays's Q4 2013 Portfolio in Review
As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $6.88B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.
- Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
- Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
- Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
- Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
- Barclays opened 582 new positions and closed 442 in Q4 2013.
- Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.
Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.